Following an interim report published in a British medical journal that the Russian vaccine of the new coronavirus was shown to be more than 90% effective, the Russian side cooperated with Japan and others to manufacture the vaccine. Indicates the intention to proceed.

Regarding the new coronavirus vaccine "Sputnik V" that has been inoculated in multiple countries such as Russia, an interim report that the Russian research institute that developed it showed 91.6% efficacy in the final stage clinical trial , Was published in the British medical journal "Lancet".



President Putin said at an online meeting within the government on the 10th that he "increased the reliability of our vaccine."



In an interview on state television broadcast on the 10th, Russian Ambassador Garuzin, who is stationed in Japan, said, "I hope that Japanese partners will fully consider opportunities to cooperate with Japan in the production of vaccines." He expressed his intention to promote cooperation with Japan toward the production of vaccines.



According to a Russian government-affiliated fund that is in charge of selling the vaccine overseas, vaccination is progressing in South America and the Middle East, and discussions are also held with some countries for local production. As a result, the Russian side is putting more effort into reaching out to each country, triggered by its publication in a British medical journal.